Author:
Zhou Xueyin,Gu Yiming,Wang Huihong,Zhou Wei,Zou Lei,Li Shuting,Hua Chunyan,Gao Sheng
Funder
National Natural Science Foundation of China
China Scholarship Council
Publisher
Springer Science and Business Media LLC
Reference162 articles.
1. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003;2(3):119–25.
2. Chamoto K, Al-Habsi M, Honjo T. Role of PD-1 in immunity and diseases. Curr Top Microbiol Immunol. 2017;410:75–97.
3. Schnell A, Bod L, Madi A, Kuchroo VK. The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity. Cell Res. 2020;30(4):285–99.
4. Dolladille C, Ederhy S, Sassier M, Cautela J, Thuny F, Cohen AA, et al. Immune checkpoint inhibitor rechallenge after immune-related adverse events in patients with cancer. JAMA Oncol. 2020;6(6):865–71.
5. Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12(6):492–9.